Entera Bio
ENTX
22 hedge funds and large institutions have $18.1M invested in Entera Bio in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more capital invested
Capital invested by funds: $17.7M → $18.1M (+$472K)
0.24% more ownership
Funds ownership: 20.14% → 20.37% (+0.24%)
0% more funds holding
Funds holding: 22 → 22 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$102K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$69.5K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$58.6K |
| 4 |
Renaissance Technologies
New York
|
+$46K |
| 5 |
SCM
Superstring Capital Management
New York
|
+$40.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bessemer Group
Woodbridge,
New Jersey
|
-$270K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$24.5K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$20.7K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$14.1K |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$13.5K |
ENTX Hedge Fund Activity: Q4 2025 in Review
22 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q4 2025, worth a combined $18.1M — up 2.7% from $17.7M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ENTX positions and 4 closed out — a net gain of 1 holder — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Jane Street, adding an estimated $102K. The largest seller was Bessemer Group, exiting entirely with an estimated $270K sold.
- 22 institutional investors held Entera Bio (ENTX) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $18.1M of Entera Bio stock for Q4 2025, up 2.7% quarter-over-quarter.
- 5 funds opened new Entera Bio positions in Q4 2025 and 4 closed out, a net change of +1 holder.
- The largest Entera Bio buyer in Q4 2025 was Jane Street, an estimated $102K added.
- The largest Entera Bio seller in Q4 2025 was Bessemer Group, an estimated $270K sold.
Based on aggregated 13F filings for Q4 2025.